Connect with us

Hi, what are you looking for?

Tech & Science

Frog foam inspires drug delivery method

Strathclyde University (U.K.) scientists have been studying the diminutive Tungara frog (Engystomops pustulosus) from Trinidad. The female frog, when mating, produces a floating foam nest. The foam nests are resistant bio-foams that protect the fertilized eggs from dehydration, sunlight, temperature, and potential pathogens until the tadpoles hatch.

Inspired by the protective foam, the researchers think simialrily tough bubbles could be used to trap and deliver medication to people who have been badly burnt, while simultaneoulsy providing a protective barrier between the wound dressing and the damaged skin.

In trials, the Scottish scientists loaded a synthetically produced foam with a dye. By studying the flow and formation, it was found that the foam was released at a steady rate, and this continued for a period of up to seven days. After this success, the group then loaded the foam with an antibiotic drug (vancomycin.) A broad-spectrum antimicrobial, vancomycin is made by the soil bacterium Amycolatopsis orientalis.

These trials showed that the drug was released again at a steady rate. More importantly, the antibiotic continued to work as intended. This was shown by assessing the antibiotic against pathogenic bacteria. While the bacteria were killed, there was no damage to healthy human cells.

It is hoped the trials will lead to the creation of a medical grade foam that will be stable and able to be used to treat burns patients. Speaking with the BBC, lead researcher Dr. Paul Hoskisson said: “‘d say we are about half way there, to making a stable foam. Once we do that, we would then need to test it in patients, but that will take a few years yet.”

The details about the foam have yet to be reported to a peer reviewed journal. However, preliminary data has been presented to the Royal Society for Microbiology’s Annual Conference, which was held recently in Liverpool.

Avatar photo
Written By

Dr. Tim Sandle is Digital Journal's Editor-at-Large for science news. Tim specializes in science, technology, environmental, business, and health journalism. He is additionally a practising microbiologist; and an author. He is also interested in history, politics and current affairs.

You may also like:

World

Boeing secured orders for nearly 1,200 commercial planes last year, topping European rival Airbus for the first time since 2018.

Business

The group has struggled with a substantial debt load and said it had initiated bankruptcy proceedings in the US Bankruptcy Court.

Business

You need advertising in AI like you need a third armpit.  

Business

The Vilnius Innovation District and CyberCity in New Town is about to host the city’s first two unicorns.